Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX), a company fueling scientific discovery... Read more.
WSFS Financial Corp.’s A- Senior Unsecured Debt Rating Affirmed with Stable Outlook by KBRA, Reflecting Strong Earnings, Liquidity, Capital and Diversified Fee Revenue
WILMINGTON, Del.–(BUSINESS WIRE)–Kroll Bond Rating Agency (KBRA) has reaffirmed the senior unsecured debt rating of A- for WSFS Financial Corporation... Read more.
BlackRock Taxable Municipal Bond Trust (BBN) Announces Distribution Dates and an Increase to the Monthly Distribution Rate
NEW YORK–(BUSINESS WIRE)–$BBN–BlackRock Taxable Municipal Bond Trust (the “Fund”) announced today an increase to its monthly distribution rate,... Read more.
SINOVAC Board Sets the Record Straight on July 8 Special Meeting of Shareholders
Special Meeting validly adjourned until the appropriate court makes a final decision on validity of the PIPE shares and will be reconvened SAIF and the Dissenting... Read more.
Orion Properties Inc. Announces Second Quarter 2025 Earnings Release and Webcast Dates
PHOENIX–(BUSINESS WIRE)–Orion Properties Inc. (NYSE: ONL) (“Orion” or the “Company”), a fully-integrated real estate investment trust which owns... Read more.
First Business Bank Announces Second Quarter 2025 Earnings Conference Call
MADISON, Wis.–(BUSINESS WIRE)–First Business Financial Services, Inc. (the “Company” or “First Business Bank”) (Nasdaq:FBIZ) invites participation... Read more.
Silgan to Release Second Quarter 2025 Earnings Results on July 30, 2025
STAMFORD, Conn.–(BUSINESS WIRE)–Silgan Holdings Inc. (NYSE: SLGN), a leading supplier of sustainable rigid packaging solutions for the world’s... Read more.
Sensient Announces Conference Call
MILWAUKEE–(BUSINESS WIRE)–Sensient Technologies Corporation (NYSE: SXT) will hold its earnings call and webcast to discuss 2025 second quarter results... Read more.
Verastem Oncology Announces Publication of the Primary Results from the Phase 2 RAMP 201 Trial of Avutometinib in Combination with Defactinib in Patients with Recurrent Low-Grade Serous Ovarian Cancer in the Journal of Clinical Oncology
Robust objective response rates were observed (31% overall, 44% in KRAS-mutant, and 17% in KRAS wild-type) in patients whose cancer had progressed after multiple... Read more.
Barings Global Short Duration High Yield Fund Announces July 2025 Monthly Distribution of $0.1223 per Share
CHARLOTTE, N.C.–(BUSINESS WIRE)–The Barings Global Short Duration High Yield Fund (the “Fund”) (NYSE: BGH) announced its monthly dividend for July... Read more.